Funding opportunities
2,259 live opportunities from Grants.gov, NIH, NSF, and more.
Biomedical & Health× remove
- Utilizing integrin-targeted PET imaging and therapeutics to predict and treat radiation-induced pulmonary fibrosisNational Cancer InstitutePAR-25-145 closes 5/31/2031up to $645,414activenih
- Immunotherapy for Glioblastoma by Targeting an Immunoregulatory NeuropeptideNational Cancer InstitutePA-25-301 closes 5/31/2031up to $567,754activenih
- Acetylation modulates T cell receptor signalingNational Cancer InstitutePA-25-301 closes 5/31/2031up to $498,582activenih
- Multimodal computational models for early prediction of peritoneal recurrence in gastric cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $513,915activenih
- Incretin Mimetics for Intercepting Obesity-Related Cancers: Effects and Underlying MechanismsNational Cancer InstitutePAR-23-279 closes 5/31/2031up to $656,285activenih
- Borrelia burgdorferi genotypic diversity, pathogenesis, and host cellular responsesNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $715,313activenih
- Lost in Translation: Inhibiting eIF4A to Treat AMLNational Cancer InstitutePA-25-301 closes 5/31/2031up to $409,463activenih
- Understanding and modulating paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury (TBI): A neuroimaging and physiologic data analytic approachNational Institute of Neurological Disorders and StrokePA-24-184 closes 5/31/2031up to $228,641activenih
- Causal Machine Learning and Trial Emulation for Precision Cardiovascular Risk Stratification in Obstructive Sleep Apnea (CLARITY-OSA)National Heart Lung and Blood InstitutePA-24-176 closes 5/31/2031up to $170,892activenih
- Lineage plasticity sensitizes FGFR3-mutant bladder cancer to FGFR inhibitorsNational Cancer InstitutePAR-25-129 closes 5/31/2031up to $637,473activenih
- Weak Cell Adhesion is a Prognostic Signature of Invasive CancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $486,094activenih
- Digital Biomarkers and Remote Testing for Neurogenic Thoracic Outlet SyndromeEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-305 closes 5/31/2031up to $484,067activenih
- Regulation of neutrophil endoplasmic reticulum stress response by IRE1aNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $599,480activenih
- Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer PatientsNational Cancer InstitutePAR-25-167 closes 5/31/2031up to $663,998activenih
- Integrins α4β7 in Leukocyte Rolling in Shear Flow, Firm Adhesion, and TherapyNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $889,904activenih
- Impact of Effective Chemoprevention in Early Childhood on the Development of Naturally Acquired Immunity to Malaria.National Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $810,125activenih
- Immune checkpoint inhibitors in patients with Rheumatoid Arthritis and Melanoma: a study using real world dataNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-24-176 closes 5/31/2031up to $129,330activenih
- Nociceptive control of bladder tumorigenesisNational Cancer InstitutePAR-25-129 closes 5/31/2031up to $688,893activenih
- Answering important questions in HIV with mismeasured clinical endpointsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $780,474activenih
- Structural and functional insights into mpox entry and neutralizationNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $897,277activenih
- Immune checkpoint receptors and their blockade in skin and gutNational Cancer InstitutePA-25-301 closes 5/31/2031up to $602,641activenih
- Efficacy of targeting GAPM3 to block acute and chronic Toxoplasma gondii infectionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $463,290activenih
- Differentiation, fate, and function of pathogenic T helper cells in graft-versus-host diseaseNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $775,740activenih
- A novel eNAMPT-neutralizing mAb to reduce antimicrobial resistance following hospital- and ventilator-associated bacterial pneumoniaNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $861,088activenih
- Selective loss of HLA gene products in driving unique breast cancer immunobiologyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $695,884activenih